Approval · Notice of Compliance 18358 · 2016
LOVASTATIN: Notice of Compliance 18358
Issued August 10, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18358
- Date
- August 10, 2016
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOVASTATIN | 02353229 | Cancelled Post Market |
| LOVASTATIN | 02353237 | Cancelled Post Market |
Medicinal ingredients
- LOVASTATIN 20 MG per TAB
- LOVASTATIN 40 MG per TAB